3648 results for «2498»
3648 results
Update on coronary physiology in 2024
17 May 2024 – From EuroPCR 2024
This session provides an update on the available options for invasive coronary physiology in 2024. It reviews the latest evidence supporting the clinical adoption of invasive physiology indexes and shares practical tips and tricks for their application. Topics covered include CT-based physiology, pressure wire-based physiology, angiography-based...
Calcified lesions: one big challenge; several good options
17 May 2024 – From EuroPCR 2024
This session delves into the management of calcified coronary lesions, presenting various techniques and tools to address this common challenge. It covers topics such as the use of drug-coated balloons, rotational atherectomy, intravascular lithotripsy, and high-pressure non-compliant balloons. The session also includes a meta-analysis on the...
Personalised Vascular Care Award ceremony
16 May 2024 – From EuroPCR 2024
This session is the Personalised Vascular Care Award ceremony, sponsored by Abbott. The objectives and details of this session are not provided, as it is likely an event to recognize and celebrate achievements in the field of personalized vascular care.
Scientific highlights, clinical trial updates and key learnings from EuroPCR 2024
17 May 2024 – From EuroPCR 2024
Davide Capodanno presents notable trial updates, coronary devices, and key takeaways from EuroPCR 2024. Highlights include the SOLVE-TAVI and IDEAL-LM trials at 5 years, BIOADAPTOR at 2 years, advancements in drug-coated balloons and DES, as well as insights from REC-CAGEFREE II, LANDMARK, and NOTION-2.
References
- SOLVE-TAVI: Feistritzer HJ, et al....
TAVR in challenging anatomies
17 May 2024 – From EuroPCR 2024
This session focuses on navigating TAVR procedures in complex anatomical scenarios. It covers topics such as optimizing the position of a TAVR valve in a stentless bioprosthesis, managing an unexpected deep position of a TAVR implant, dealing with a completely radiolucent failing surgical bioprosthetic valve, and...
ACS: how to approach special clinical scenarios
17 May 2024 – From EuroPCR 2024
This session focuses on the management of acute coronary syndrome (ACS) in special clinical scenarios. It covers topics such as treating ACS with multivessel disease, managing an ACS and unstable patient, and addressing subacute myocardial infarction. The session features case presentations and discussions, providing insights and...
Thrombus management in a STEMI patient with high clot burden
17 May 2024 – From EuroPCR 2024
Discover the optimal timing for thrombus extraction and explore effective strategies for managing large thrombi. Learn about the latest tools and techniques, as well as the role of pharmacotherapy in supporting successful thrombus removal.
TAVI: how to prevent stroke
17 May 2024 – From EuroPCR 2024
This session focuses on strategies for preventing stroke during TAVI procedures. It features case presentations and discussions on the use of cerebral protection devices, including a novel full-body embolic protection device, and the management of complications such as cerebral hyperperfusion syndrome.
Transcatheter solutions for combined valve disease
17 May 2024 – From EuroPCR 2024
This session delves into the transcatheter management of patients with combined valve disease, including cases of concomitant aortic stenosis and mitral regurgitation, failed bioprostheses in both the aortic and mitral valves, and severe aortic regurgitation after previous valve-sparing root replacement. The session features case presentations and...
Thrombectomy for pulmonary embolism
16 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on catheter-directed therapy for pulmonary embolism. It includes presentations and discussions on an intelligent CT vacuum aspiration thrombectomy system, outcomes of catheter-directed therapy in intermediate-high and high-risk pulmonary embolism, and functional and quality of life outcomes in...
"Rock" around the clock: differential use of the dedicated tools to deal with coronary calcific lesions
16 May 2024 – From EuroPCR 2024
This session, with the collaboration of the Argentinian College of Interventional Cardioangiologists (CACI), Italian Society of Interventional Cardiology (SICI-GISE) and Interventional Department of the Chilean Society of Cardiology, provides insights on modern treatment algorithms for calcific coronary lesions. It covers best practices for different devices to...
CTO PCI: from planning to execution
16 May 2024 – From EuroPCR 2024
This session, with the collaboration of the Cyprus Society of Cardiology / Cyprus Interventional Cardiology Working Group, Tunisian Group for Interventional Cardiology and Bulgarian Society of Interventional Cardiology, covers planning and execution of CTO PCI procedures. It includes case discussions on treatment dilemmas, overcoming frequently encountered...
Comparative insights into QFR, FFR, and angiography
16 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on various aspects of assessing and managing multivessel coronary artery disease. It includes presentations and discussions on the use of quantitative flow ratio (QFR) for assessing non-culprit lesions in acute myocardial infarction, functional assessment of surgical revascularization,...
PCR's Got Talent - Round 2 - Session 2
15 May 2024 – From EuroPCR 2024
This session features a selected abstract submission from EuroPCR 2024 on plaque characterization, outcomes, and predictors of recurrent events in stent failure, as studied using optical coherence tomography (OCT).
PCR's Got Talent - Round 2 - Session 1
15 May 2024 – From EuroPCR 2024
Randomised trials: substudies and extended follow-up - A quick update
15 May 2024 – From EuroPCR 2024
This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...
TEER for primary mitral regurgitation - LIVE case
15 May 2024 – From EuroPCR 2024
A 76-year-old male, with previous CABG in 2015, hypertension, diabetes, and pulmonary hypertension (WHO2), presented with severe symptomatic primary MR (P3 flail).
The operators implanted 1 MitraClip (XTW) step-by-step, from the transseptal puncture to the closure, guided by TEE echo and under general anaesthesia, via the venous...
Renal interventions
15 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on renal interventions. It will cover various topics, including a novel approach to handle renal artery stenoses, an interesting case of paroxysmal nocturnal dyspnoea, accessory arteries in renal denervation and OCT, as well as renal denervation...
Cardiogenic shock in women : different cause, different treatment
15 May 2024 – From EuroPCR 2024
This session will feature selected EuroPCR 2024 Clinical Case submissions focused on cardiogenic shock in women. Attendees will have the opportunity to learn about the proposed diagnoses and treatments, as well as the actual outcomes, for these challenging cases. The session will also include discussions and...
Unusual cases of PFO closure
15 May 2024 – From EuroPCR 2024
This session will feature selected EuroPCR 2024 Clinical Case submissions focused on unusual cases of patent foramen ovale (PFO) closure. Attendees will have the opportunity to explore challenging cases, such as unexplained hypoxemia in an elderly man post-lung cancer lobectomy, a case of persistent dyspnea and...
